Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Aug:240:217-224.
doi: 10.1016/j.ajo.2022.02.027. Epub 2022 Mar 12.

Risk Factors for Failure of Tube Shunt Surgery: A Pooled Data Analysis

Affiliations
Randomized Controlled Trial

Risk Factors for Failure of Tube Shunt Surgery: A Pooled Data Analysis

Eileen C Bowden et al. Am J Ophthalmol. 2022 Aug.

Abstract

Purpose: To identify the risk factors associated with failure of tube shunt surgery.

Design: Pooled analysis of 3 prospective multicenter, randomized clinical trials.

Methods: A total of 621 patients with medically uncontrolled glaucoma were enrolled, including 276 from the Ahmed Baerveldt Comparison Study, 238 from the Ahmed Versus Baerveldt Study, and 107 from the tube group of the Tube Versus Trabeculectomy Study. Patients were randomized to treatment with an Ahmed glaucoma valve (model FP7) or Baerveldt glaucoma implant (model 101-350). The associations between baseline risk factors and tube shunt failure were assessed using a Cox proportional hazards regression model. The primary outcome measure was the rate of surgical failure defined as intraocular pressure (IOP) > 21 mmHg or reduced < 20% from baseline, IOP ≤ 5 mmHg, loss of light perception vision, reoperation for glaucoma, or removal of implant.

Results: The cumulative probability of failure after tube shunt surgery was 38.3% after 5 years. In multivariable analyses, baseline factors that predicted tube shunt failure included preoperative IOP (≤ 21 mmHg compared to IOP > 21 and ≤ 25 mmHg; HR, 2.34; 95% CI, 1.52-3.61; P < .001), neovascular glaucoma (HR, 1.79; 95% CI, 1.28-2.52; P = .001), randomized treatment (for Ahmed glaucoma valve; HR, 1.36; 95% CI, 1.04-1.78; P = .025), and age (for 10 year decrease in age; HR, 1.19; 95% CI, 1.09-1.31; P < .001).

Conclusions: Lower preoperative IOP, neovascular glaucoma, Ahmed implantation, and younger age were predictors of tube shunt failure. This Study provides the largest prospectively collected dataset on tube shunt surgery.

PubMed Disclaimer

Conflict of interest statement

The other authors indicate no financial support or conflicts of interest.

Figures

Figure 1.
Figure 1.
Kaplan-Meier survival curve showing the cumulative probability of failure of tube shunt surgery.

Similar articles

  • Aqueous shunts for glaucoma.
    Tseng VL, Coleman AL, Chang MY, Caprioli J. Tseng VL, et al. Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD004918. doi: 10.1002/14651858.CD004918.pub3. Cochrane Database Syst Rev. 2017. PMID: 28750481 Free PMC article. Review.
  • The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.
    Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ, Mura JJ, Cantor LB, Ahmed II. Christakis PG, et al. Ophthalmology. 2016 Oct;123(10):2093-102. doi: 10.1016/j.ophtha.2016.06.035. Epub 2016 Aug 17. Ophthalmology. 2016. PMID: 27544023 Clinical Trial.
  • The Ahmed versus Baerveldt study: three-year treatment outcomes.
    Christakis PG, Tsai JC, Kalenak JW, Zurakowski D, Cantor LB, Kammer JA, Ahmed II. Christakis PG, et al. Ophthalmology. 2013 Nov;120(11):2232-40. doi: 10.1016/j.ophtha.2013.04.018. Epub 2013 Jun 21. Ophthalmology. 2013. PMID: 23796764 Clinical Trial.
  • The Ahmed Versus Baerveldt study: one-year treatment outcomes.
    Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, Ahmed II. Christakis PG, et al. Ophthalmology. 2011 Nov;118(11):2180-9. doi: 10.1016/j.ophtha.2011.05.004. Epub 2011 Sep 1. Ophthalmology. 2011. PMID: 21889801 Clinical Trial.
  • New developments in tube shunt surgery.
    Chen J, Gedde SJ. Chen J, et al. Curr Opin Ophthalmol. 2019 Mar;30(2):125-131. doi: 10.1097/ICU.0000000000000549. Curr Opin Ophthalmol. 2019. PMID: 30562244 Review.

Cited by

References

    1. Arora KS, Robin AL, Corcoran KJ, Corcoran SL, Ramulu PY. Use of various glaucoma surgeries and procedures in Medicare beneficiaries from 1994 to 2012. Ophthalmology 2015;122:1615–1624. - PubMed
    1. Chen PP, Yamamoto T, Sawada A, et al. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. J Glaucoma 2007;16:14–19. - PubMed
    1. Joshi AB, Parrish RK, Feuer WF. 2002 survey of the American Glaucoma Society: Practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005;14:172–174. - PubMed
    1. Desai MA, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: A survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging 2011;42:202–208. - PubMed
    1. Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma 2017;26:687–693. - PMC - PubMed

Publication types